Although TSA is approved for the treatment of some types of cancer, the possibility of TSA-induced cancers and other toxin-related, mutagenic-related side-effects should greatly limit the use of HDAC inhibitors to treat only dire human conditions [53]. Here, HDAC9 is linked to cancer.